You are here

alemtuzumab

Sanofi, Cellectis team up to pair Lemtrada with allogeneic CAR-Ts; Bristol Myers joins Evotec's drive to advance UK science

Endpoints

Thu, 05/13/21 - 11:59 pm

allogeneic cells

Alemtuzumab (Lemtrada) Significantly Reduces Relapses in Multiple Sclerosis vs Interferon Beta-1a in a Phase III Study

Yahoo/BusinessWire

Sat, 10/22/11 - 12:30 pm

multiple sclerosis

Phase III Data Mixed on Sanofi's Lemtrada

Yahoo/Zacks.com

Wed, 07/13/11 - 06:25 pm

multiple sclerosis

Genzyme advances key drug in Sanofi deal

Bizjournals.com

Thu, 04/14/11 - 06:23 pm

multiple sclerosis

Can Genzyme Make $3.5B a Year Giving Away a Drug for Free?

BNET Pharma

Sat, 11/27/10 - 12:53 pm

multiple sclerosis

Genzyme's MS Drug Shows Promise

Seeking Alpha

Fri, 09/18/09 - 11:21 am

multiple sclerosis